RORγt inhibitor 3 is an orally active and potent retinoic acid receptor-related orphan receptor gamma-t (RORγt) inhibitor; it exhibits high binding affinity and inhibitory activity against Th17 cell differentiation; it demonstrates therapeutic efficacy in mouse models of experimental autoimmune encephalomyelitis (EAE) and collagen-induced arthritis (CIA).